Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 28, 2026

Visa, Mastercard Aren't The Real Casualties In Citrini's AI-Stablecoin Scenario

View original at finance.yahoo.com
Visa, Mastercard Aren't The Real Casualties In Citrini's AI-Stablecoin Scenario Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Card-focused banks including American Express, Synchrony, Capital One, and Discover carry the sharpest exposure, noting their 'moats were made of friction'

    80% confidence
  • Visa and Mastercard take only a small number of basis points and pride themselves on being 'technology companies', while most of that 2-3% goes to issuers and other intermediaries

    80% confidence
  • When software controls transactions, it optimizes for efficiency, putting pressure on models built on friction and fees

    80% confidence
  • If AI agents are optimizing for cost and efficiency, they will naturally route transactions toward cheaper rails when possible

    80% confidence
  • The market reaction conflated two distinct layers of the payments stack - networks versus issuers

    80% confidence
  • AI agents will autonomously reroute transactions away from card networks toward stablecoin rails, wiping out interchange economics

    80% confidence
  • The Citrini piece got the direction right while misidentifying the primary casualties

    80% confidence
  • In machine-to-machine commerce, a 2-3% interchange fee is significant, especially when stablecoins can settle near-instantly at a fraction of the cost

    80% confidence
  • Incumbents won't vanish overnight, but companies are already exploring stablecoins and alternative rails, because even a 1-2% savings can materially change the economics for low-margin businesses

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Visa, Mastercard Aren't The Real Casualties In Citrini's AI-Stablecoin Scenario — Source | Via News | ViaNews EU